Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-29 Purchase | 2022-07-01 4:05 pm | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 20,000 | $1.71 | $34,200 | 27,754 (Indirect Direct) | View |
| 2022-03-25 Purchase | 2022-03-28 08:00 am | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 100,000 | $0.245 | $24,500 | 248,024 (Indirect Direct) | View |
| 2021-09-28 Purchase | 2021-09-28 5:04 pm | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 12,000 | $0.61 | $7,320 | 148,024 (Indirect Direct) | View |
| 2021-03-24 Purchase | 2021-03-25 07:00 am | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 16,733 | $1.32 | $22,088 | 136,024 (Indirect Direct) | View |
| 2020-12-30 Purchase | 2021-01-04 5:01 pm | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 35,000 | $0.68 | $23,800 | 119,291 (Indirect Direct) | View |
| 2020-08-13 Purchase | 2020-08-17 09:03 am | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 60,000 | $0.91 | $54,600 | 84,291 (Indirect Direct) | View |
| 2019-12-03 Purchase | 2019-12-04 07:00 am | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 20,000 | $1.159 | $23,180 | 24,291 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-27 Option Award(A) | 2024-03-06 5:01 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 3,448,911 | $0 | 3,448,911 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 5:08 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 3,448,911 | $0 | 3,448,911 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:34 pm | 2024-02-23 2033-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 1,400,000 | $0 | 1,400,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:17 pm | 2023-02-15 2032-02-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 20,000,000 | $0 | 20,000,000 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 5:54 pm | 2022-02-23 2031-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 6,000,000 | $0 | 6,000,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-06 6:22 pm | 2021-05-04 2030-05-04 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 4,000,000 | $0 | 4,000,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 4:22 pm | 2021-02-25 2030-02-25 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 240,000 | $0 | 240,000 (Direct) | View |